Log in to search using one of your social media accounts:

 

Google Doodle Celebrates Renowned Organic Chemist Asima Chatterjee
Saturday’s Google Doodle paid homage to Asima Chatterjee, a renowned organic chemist from India. Saturday marks what would have been Chatterjee’s 100th birthday. The chemist died at the age of 89 in 2006. Chatterjee was the first woman to receive a Doctorate of Science in India and her work involved many breakthroughs in medicine. According to her Google Doodle page, her work contributed to the development of treatments for epilepsy, malaria and chemotherapy. Chatterjee was also given high honors in India. She received the Padma Bhushan, which is the third-highest award a civilian can receive in India. She was ...
Source: TIME.com: Top Science and Health Stories - September 23, 2017 Category: Consumer Health News Authors: Lisa Marie Segarra Tags: Uncategorized Google onetime Source Type: news

Roche receives EU approval of TECENTRIQ ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer
Roche today announced that the European Commission (EC) has granted a marketing authorisation for TECENTRIQ (atezolizumab) as a monotherapy for the treatment of people with locally advanced or metastatic non-small cell lung cancer (NSCLC) after they have been previously treated with chemotherapy regardless of PD-L1 status. (Source: Roche Investor Update)
Source: Roche Investor Update - September 22, 2017 Category: Pharmaceuticals Source Type: news

Roche receives EU approval of TECENTRIQ ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer
Roche today announced that the European Commission (EC) has granted a marketing authorisation for TECENTRIQ (atezolizumab) as a monotherapy for the treatment of people with locally advanced or metastatic non-small cell lung cancer (NSCLC) after they have been previously treated with chemotherapy regardless of PD-L1 status. (Source: Roche Media News)
Source: Roche Media News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Yoga May Bring Better Sleep to Breast Cancer Patients
FRIDAY, Sept. 22, 2017 -- A certain type of yoga may provide lasting benefits for breast cancer patients who have trouble sleeping, researchers report. The study included 227 women undergoing chemotherapy for breast cancer who were randomly... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 22, 2017 Category: General Medicine Source Type: news

Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma
Roche announced today that the European Commission has approved Gazyvaro ® (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people achieving a response, as a new treatment for previously untreated advanced follicular lymphoma. (Source: Roche Investor Update)
Source: Roche Investor Update - September 22, 2017 Category: Pharmaceuticals Source Type: news

Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma
Roche announced today that the European Commission has approved Gazyvaro ® (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people achieving a response, as a new treatment for previously untreated advanced follicular lymphoma. (Source: Roche Media News)
Source: Roche Media News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Discovery of a new genetic syndrome which predisposes the body to cancer
(Universitat Autonoma de Barcelona) A new syndrome caused by biallelic mutations -- those produced in both gene copies inherited from the mother and father -- in the FANCM gene predisposes the body to the appearance of tumors and causes rejection to chemotherapy treatments. Contrary to what scientists believed, the gene does not cause Fanconi anaemia. Researchers recommend modifying the clinical monitoring of patients with these mutations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 22, 2017 Category: Cancer & Oncology Source Type: news

Forgoing chemo linked to worse survival in older patients with advanced colon cancer who had dementia
(American Association for Cancer Research) A pre-existing diagnosis of dementia was associated with increased risk of death for older patients with advanced colon cancer; however, some of the effects of dementia on survival could be mediated by receipt of chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 22, 2017 Category: Cancer & Oncology Source Type: news

Tiny diamonds could become best friends to youths with cleft palates
This study showed that our method has a contained, targeted and sustained effect, so we’re very excited about it,” Hong said.Previous experiments showed nanodiamonds to be safe within the body and to be excreted normally. Similarly, earlier work demonstrated that enzymes break down hydrogel.The researchers plan to continue laboratory studies and hope to bring their treatment to clinical trials. Their approach has implications for treating other craniofacial conditions and sleep apnea, as well as healing wounds and bone injuries.Other authors of the study were Dong-Keun Lee, Lawrence Lin, Hsin Chuan Pan, Deborah...
Source: UCLA Newsroom: Health Sciences - September 22, 2017 Category: Universities & Medical Training Source Type: news

Egg Freezing May Not Delay Chemo for Breast Cancer Patients Egg Freezing May Not Delay Chemo for Breast Cancer Patients
Women diagnosed with breast cancer who want to freeze their eggs and embryos before tumor treatment leads to infertility can do this without delaying the start of chemotherapy, a U.S. study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 21, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

The Baby of a Mother Who Refused Chemo to Give Birth Has Died
(DETROIT) — The baby born of a Michigan woman who chose to forgo chemotherapy to give birth to the child has died, a relative said Thursday. Sonya Nelson said her niece, Life Lynn DeKlyen, died Wednesday evening at the University of Michigan Hospital in Ann Arbor. Life’s mother, Carrie DeKlyen, died Sept. 9, three days after giving birth to her sixth child. Relatives said Life had been doing better than expected after being born prematurely at 1 pound, 4 ounces (567 grams). Nelson told The Associated Press the baby had good and bad days at the hospital, but “took a turn for the worse” this week. &ld...
Source: TIME.com: Top Science and Health Stories - September 21, 2017 Category: Consumer Health News Authors: Jeff Karoub / AP Tags: Uncategorized APW Michigan onetime Source Type: news

Cancer industry frustrated that children treated with chemotherapy aren't getting enough HPV vaccines
(Natural News) The Advisory Committee on Immunization Practices, the panel that makes vaccine policy recommendations for the mainstream medical community, has for several years now been pushing for the routine HPV vaccination of young boys and girls. Their recommendation has also been endorsed by many other health organizations. Along with the rest of the adolescent... (Source: NaturalNews.com)
Source: NaturalNews.com - September 21, 2017 Category: Consumer Health News Source Type: news

Parker Institute begins dosing in Phase Ib/II combination trial for pancreatic cancer
The Parker Institute for Cancer Immunotherapy and Cancer Research Institute in the US have started dosing patients in a Phase Ib/II clinical trial to investigate the combination of standard chemotherapy and immunotherapy for the treatment of pancreat … (Source: Drug Development Technology)
Source: Drug Development Technology - September 20, 2017 Category: Pharmaceuticals Source Type: news

Yoga Improves Sleep In People Being Treated For Cancer
People receiving chemotherapy are often plagued by insomnia at night and excessive drowsiness during the day. But a new study in the journal Cancer suggests that yoga can help. Breast cancer patients in the study who practiced at home at least twice a week reported better sleep quality over time, compared to those who practiced less often or not at all. The new research is “another piece of evidence, along with now dozens of studies, showing that incorporating a mind-body practice within conventional cancer care can help decrease side effects for patients,” says lead author Lorenzo Cohen, director of the integr...
Source: TIME.com: Top Science and Health Stories - September 20, 2017 Category: Consumer Health News Authors: Amanda MacMillan Tags: Uncategorized Alternative Medicine Breast Cancer breast cancer treatment breathing exercises chemotherapy Exercise/Fitness fatigue insomnia Meditation sleep tibetan yoga TIME Health Breast Cancer Source Type: news

Egg freezing may not delay chemo for breast cancer patients
(Reuters Health) - Women diagnosed with breast cancer who want to freeze their eggs and embryos before tumor treatment leads to infertility can do this without delaying the start of chemotherapy, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

How to manage family life when your child has cancer
Valerie, with husband Doron, son Evan and daughter Ruby When our daughter, Ruby, was diagnosed with acute lymphoblastic leukemia (ALL) at one and a half years old, my husband and I were immediately transformed from working parents with two young children, to parental caregivers for a child with cancer. Between hospital stays, medications and appointments, there was so much to keep track of. It can be overwhelming at times, but there are ways to manage life after your child is diagnosed with cancer. Settle into to this new normal. It can be easy to stay in crisis mode when something like a cancer diagnosis interrupts y...
Source: Thrive, Children's Hospital Boston - September 20, 2017 Category: Pediatrics Authors: Valerie Graf Tags: Diseases & Conditions Parenting Cancer Dana-Farber/Boston Children's Cancer and Blood Disorders Center Source Type: news

Tibetan yoga practice may improve sleep quality for breast cancer patients receiving chemotherapy
(University of Texas M. D. Anderson Cancer Center) Participating in twice-weekly practice of Tibetan yoga may reduce sleep disturbances and improve sleep quality in breast cancer patients receiving chemotherapy, according to a study from researchers at The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 20, 2017 Category: Cancer & Oncology Source Type: news

New study suggests jet lag drug benefits patients undergoing chemotherapy
A recent study conducted by scientists at the Universities of Edinburgh and Aberdeen has suggested that painful side effects from cancer medicines can be managed using melatonin, a drug that helps ease the effects of jet lag. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 19, 2017 Category: Pharmaceuticals Source Type: news

CIRSE 2017 Round-up: Delcath touts second-gen hemofiltration system in percutaneous hepatic perfusion
Delcath Systems (NSDQ:DCTH) touted data today from a study of its second-generation hemofiltration system in patients undergoing percutaneous hepatic perfusion with melphalan hydrochloride. The New York-based company presented the results from its study at the Cardiology and Interventional Radiology of Europe annual meeting in Copenhagen, Denmark. The investigational product, an injectable melphalan hydrochloride for use with Delcath’s hepatic delivery system, is designed to administer high-dose chemotherapy to the liver while limiting systemic exposure and side effects. Get the full story at our sister site, Dr...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat Delcath Systems Inc. Source Type: news

Jet lag drug could lessen chemotherapy pain
Melatonin could significantly improve chemotherapy-induced neuropathic pain, a study published in theJournal of Pineal Researchreports.The Telegraph (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 18, 2017 Category: Endocrinology Source Type: news

How bacteria hinder chemotherapy
(Weizmann Institute of Science) Scientists find bacteria in pancreatic tumors that metabolize a common drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 18, 2017 Category: Cancer & Oncology Source Type: news

Chemotherapy pain could be eased by jetlag drug, study suggests
(University of Edinburgh) Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag, research suggests. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 15, 2017 Category: Cancer & Oncology Source Type: news

Cannabis beats "incurable" brain tumor after chemo fails
(Natural News) A Scottish woman given just months to live back in 2013 claims that she has cannabis oil to thank for the fact that she has been in remission for nearly four years. After being diagnosed with an incurable brain tumor, Lynn Cameron was subjected to the usual assault of surgery, chemotherapy and radiation... (Source: NaturalNews.com)
Source: NaturalNews.com - September 14, 2017 Category: Consumer Health News Source Type: news

Selena Gomez Had a Kidney Transplant for Lupus. What Is That?
This article originally appeared on Health.com (Source: TIME.com: Top Science and Health Stories)
Source: TIME.com: Top Science and Health Stories - September 14, 2017 Category: Consumer Health News Authors: Amanda MacMillan / Health Tags: Uncategorized celebrities kidney transplant lupus lupus symptoms public health Selena Gomez Selena gomez disease Selena gomez Kidney Transplant Selena Gomez lupus what disease does selena gomez have What is lupus Why did selena gomez Source Type: news

Medical News Today: Single molecule determines lung cancer cell death
A new study finds that one molecule is key to whether or not particular lung cancer cells respond to chemotherapy and undergo programmed cell death. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 14, 2017 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Monopar receives licence to develop Onxeo ’s Validive oral mucositis treatment
Onxeo has granted a global exclusive licence to Monopar Therapeutics for its Validive (clonidine mucoadhesive buccal) tablet used to treat severe oral mucositis induced by radiotherapy or chemotherapy in patients suffering from head and neck cancer. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 13, 2017 Category: Pharmaceuticals Source Type: news

Preventing childhood deafness following chemotherapy treatment
(Frontiers) A UK charity backs a pioneering new project to prevent childhood deafness following treatment with life-saving cancer drugs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 12, 2017 Category: Cancer & Oncology Source Type: news

Best poster at ESMO 2017 shows positive trials twice as likely to be reported in lay press
(European Society for Medical Oncology) Randomized controlled trials with positive results are twice as likely to be reported by the lay press as those with negative trials, according to results from the Best Poster in Public Health and Health Economics at the ESMO 2017 Congress in Madrid. Trials on immunotherapy and targeted therapy were more commonly reported than those on chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 12, 2017 Category: Cancer & Oncology Source Type: news

Chemotherapy, pain, and gut microbiota
Chemotherapy triggers gut microbiota to stimulate pain-associated peripheral inflammation. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 12, 2017 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

Florida ’ s hospitals weather the storm
Doctors, nurses and staff at hospitals up and down Florida's Gulf and Atlantic coasts were nearly breathless with surprise and relief Monday: Their patients — and their buildings — had survived the monster named Irma. “We're wonderful,” said Cheryl Garn, spokeswoman for Lee Health's four hospitals in Fort Myers. “Minimum damage. The sun is out and shining. […]Related:New clinical trial might change the standard treatment for melanomaShe rejected chemotherapy and chose to die of cancer — so she could give birth to her childAs Irma looms, many Florida hospitals turn off th...
Source: Washington Post: To Your Health - September 11, 2017 Category: Consumer Health News Source Type: news

Hint of Survival Gain With Ramucirumab in Urothelial Cancer Hint of Survival Gain With Ramucirumab in Urothelial Cancer
Patients with progressive urothelial cancer after platinum-based chemotherapy may benefit with the antiangiogenesis drug ramucirumab, although the absolute gain is small, trial results suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mom who chose baby over chemotherapy dies
Doctors say Carrie DeKlyen chose to forgo chemotherapy to treat her brain cancer since it would have meant ending her pregnancy (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 11, 2017 Category: Consumer Health News Source Type: news

Chemoradiotherapy Remains Standard of Care in Cervical Cancer Chemoradiotherapy Remains Standard of Care in Cervical Cancer
Chemoradiotherapy remains the standard of care for cervical cancer patients with locally advanced disease, concludes an Indian trial that compared it to neoadjuvant chemotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

KEYNOTE-040 evaluates pembrolizumab in head and neck cancer
(European Society for Medical Oncology) Immunotherapy with the checkpoint inhibitor pembrolizumab may be a better option than standard treatments for patients whose head and neck cancer has spread, or recurred after an initial round of chemotherapy, according to results of the Keynote-040 trial presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 11, 2017 Category: Cancer & Oncology Source Type: news

Savings less than expected for generic oral chemotherapy
(UNC Lineberger Comprehensive Cancer Center) The cost savings for the generic versions of an orally administered cancer treatment were less than expected in an analysis led by researchers from the UNC Lineberger Comprehensive Cancer Center. Their findings call into question the impact generic drugs can have on controlling health care costs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 11, 2017 Category: Cancer & Oncology Source Type: news

She rejected chemotherapy and chose to die of cancer — so she could give birth to her child
The headaches began sometime in March. They didn’t think much of them, other than that they were possible migraines — until she started vomiting. An initial scan showed a mass in Carrie DeKlyen’s brain. More tests showed that it was a form of cancer, possibly lymphoma, but treatable. But a pathology exam revealed a more grim […]Related:New clinical trial might change the standard treatment for melanomaAs Irma looms, many Florida hospitals turn off the lightsHouston’s next big storm: Mosquitoes (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 10, 2017 Category: Consumer Health News Source Type: news

Debate on duration of colon cancer adjuvant chemotherapy takes centre stage at ESMO 2017
(European Society for Medical Oncology) The debate on whether to shorten adjuvant chemotherapy for colon cancer from six to three months takes center stage today in a special session at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2017 Category: Cancer & Oncology Source Type: news

Ramucirumab plus docetaxel improves progression-free survival in urothelial cancer
(European Society for Medical Oncology) Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2017 Category: Cancer & Oncology Source Type: news

Mature results favor pembrolizumab as second-line treatment for bladder cancer
(European Society for Medical Oncology) Mature results from the KEYNOTE-045 trial to be presented today at the ESMO 2017 Congress in Madrid have confirmed significantly longer survival in patients with advanced urothelial cancer who receive the checkpoint inhibitor pembrolizumab after initial chemotherapy, compared to an alternative chemotherapy regimen. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2017 Category: Cancer & Oncology Source Type: news

Woman who chose baby instead of chemotherapy has died
A Michigan woman who gave up the opportunity to prolong her life in order to give birth to her sixth child has died (Source: ABC News: Health)
Source: ABC News: Health - September 9, 2017 Category: Consumer Health News Tags: US Source Type: news

‘I’ll See You in Heaven.’ Woman Who Chose Her Baby Instead of Chemotherapy Dies
(DETROIT) — A Michigan woman who sacrificed the chance to prolong her life in order to give birth to her sixth child has died. Nick DeKlyen tells The Associated Press that his wife, Carrie DeKlyen, died early Saturday surrounded by family. He says among the last things he said to her were, “I’ll see you in Heaven.” Doctors removed Carrie DeKlyen’s feeding and breathing tubes on Thursday, a day after she gave birth to her daughter Life Lynn DeKlyen. The mother chose to forgo chemotherapy to treat her brain cancer, since it would have meant ending her pregnancy. Life Lynn was born prematurely an...
Source: TIME.com: Top Science and Health Stories - September 9, 2017 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized APW Detroit onetime Source Type: news

Study confirms chemoradiation is best treatment for locally advanced cervical cancer
(European Society for Medical Oncology) A 14-year randomized trial in more than 600 patients has concluded that chemoradiation should remain the standard treatment for patients with locally advanced cervical cancer. The findings are reported today at the ESMO 2017 Congress in Madrid. The trial demonstrated no improved disease-free survival with neoadjuvant chemotherapy followed by surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2017 Category: Cancer & Oncology Source Type: news

chemoWave: Patients Data-Sharing With Clinicians chemoWave: Patients Data-Sharing With Clinicians
A lot can go wrong when cancer patients undergo weeks of chemotherapy. A new app allows for symptom reporting and other vital communication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

CT Abnormality in Patient With Stage II Breast Cancer History
A 57-year-old woman with a history of stage IIB breast cancer (ypT2N1M0) status post neoadjuvant chemotherapy and left partial mastectomy presents to the radiation oncology clinic for CT simulation in preparation for breast radiotherapy. Noncontrast CT scan incidentally found the abnormality depicted with arrows below. (Source: CancerNetwork)
Source: CancerNetwork - September 8, 2017 Category: Cancer & Oncology Authors: Joseph Miccio, MD Tags: Image IQ Source Type: news

Lynn Cameron claims cannabis oil CURED her brain tumour
Lynn Cameron, 48, from Blantyre, Scotland was given just 'six to 18 months' after her grade 4 tumour failed to respond to chemotherapy. She claims cannabis oil made her mass disappear. (Source: the Mail online | Health)
Source: the Mail online | Health - September 8, 2017 Category: Consumer Health News Source Type: news

Merck's immunotherapy, chemo mix shows extended lung cancer gains
MADRID (Reuters) - Giving Merck& Co's immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to provide durable benefits, according to an update of a closely watched clinical trial. (Source: Reuters: Health)
Source: Reuters: Health - September 7, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Lower dose of chemotherapy effective for liver cancer patients: Study
Researchers at the University of Pennsylvania report that patients with a common type of liver cancer can start treatment with a lower dose of chemotherapy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 6, 2017 Category: Consumer Health News Source Type: news

Zika virus may be useful in treating brain tumours
Conclusion This is an interesting piece of research that shows how knowledge in one field of medicine can sometimes be applied to another field with surprising results. But it's important to be realistic about the stage of research. This is very much a "proof of concept" study, and tests on cells, tissues and mice don't necessarily translate into a safe and effective treatment for humans. The study has several limitations, but the fact the treatment so far hasn't been tested on humans is the most important. For one thing, Zika virus doesn't naturally infect mice, so researchers had to use a specially engineered v...
Source: NHS News Feed - September 6, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Roche presents data from global phase III study showing significant clinical benefit of Alecensa (alectinib) in later-line advanced ALK-positive lung cancer
Roche today announced results from the global phase III ALUR study showing that Alecensa ® significantly reduced the risk of disease worsening or death (progression-free survival, PFS) by 85% compared to chemotherapy in patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), who had progressed following treatment with platinum-based chemothe rapy and crizotinib (hazard ratio [HR]=0.15, 95% CI: 0.08-0.29, p (Source: Roche Investor Update)
Source: Roche Investor Update - September 6, 2017 Category: Pharmaceuticals Source Type: news